These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1721446)

  • 21. Mercury-induced renal autoimmunity in BN-->LEW.1N chimeric rats.
    Kosuda LL; Greiner DL; Bigazzi PE
    Cell Immunol; 1994 Apr; 155(1):77-94. PubMed ID: 8168152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor cells in the thoracic duct lymph of tolerant, spleen-grafted rats.
    Stepkowski SM; Duncan WR; Smith JP; Bitter-Suermann H
    Can J Surg; 1984 Jan; 27(1):22-4. PubMed ID: 6235907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic studies of alloantibody response to donor alloantigens following donor-specific transfusion and lung transplantation in rats.
    Hara M; Shibata K; Kimura H; Shinomiya T; Koga Y
    Transplant Proc; 1995 Apr; 27(2):1577-9. PubMed ID: 7725415
    [No Abstract]   [Full Text] [Related]  

  • 24. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 25. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected.
    Jaskłowska-Englisz M; Olszewski WL
    Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224
    [No Abstract]   [Full Text] [Related]  

  • 26. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 27. Sponge allograft effector cells exert suppressor function via an L-arginine-dependent mechanism.
    Langrehr JM; Hoffman RA; Lee KW; Billiar TR; Schraut WH; Simmons RL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):839-40. PubMed ID: 1825002
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of prostaglandin E in the natural suppressor activity of spleen cells from newborn rats.
    Bubak-Satora M; Stĕdra J; Holan V; Kubera M; Mazur-Kolecka B; Skowron-Cendrzak A
    Folia Biol (Praha); 1988; 34(3):202-6. PubMed ID: 2974433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
    Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331
    [No Abstract]   [Full Text] [Related]  

  • 30. The induction of immunologic unresponsiveness by antigen pretreatment is mediated by a CD4 T cell that appears transiently in the spleen and subsequently in the TDL.
    Quigley RL; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):377-8. PubMed ID: 2523136
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental autoimmune encephalomyelitis in mice: Lyt and Ia phenotypes of the effector and suppressor cells.
    Bernard CC; Mackay IR
    Prog Clin Biol Res; 1984; 146():277-84. PubMed ID: 6232623
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 33. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.
    Mochizuki M; Kuwabara T; McAllister C; Nussenblatt RB; Gery I
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):1-9. PubMed ID: 3967952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for local helper and suppressor function at the site of allograft rejection.
    Ascher NL; Hoffman R; Chen S; Simmons RL
    Surgery; 1980 Aug; 88(2):274-80. PubMed ID: 6446779
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS; Bowker RJ; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1529-33. PubMed ID: 2949828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional activity of spleen and peripheral blood lymphocytes during stress-induced immunodepression].
    Iagmurov OD; Ogurtsov RP
    Biull Eksp Biol Med; 1996 Jul; 122(7):64-8. PubMed ID: 9303705
    [No Abstract]   [Full Text] [Related]  

  • 38. Myelopeptide-1 blocks the T-suppressor activity.
    Petrov RV; Mikhailova AA; Kirilina EA
    Folia Biol (Praha); 1994; 40(6):455-61. PubMed ID: 7589703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection.
    Hall BM; Gurley KE; Dorsch SE
    Transplantation; 1985 Sep; 40(3):336-9. PubMed ID: 2930923
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.